Article
AKT1 and genetic vulnerability to bipolar disorder.
Psychiatry research - 1 Feb 2020
Millischer Vincent, Matheson Granville J, Martinsson Lina, Römer Ek Inger, Schalling Martin, Lavebratt Catharina, Backlund Lena
Abstract excerpt
AKT1 encodes a serine/threonine kinase that has as one of its best-known substrates glycogen synthase kinase-3 (GSK3), a primary target for lithium. AKT1 has been previously been implicated as a vulnerability gene for bipolar disorder (BD). We aimed to associate genetic variants in the AKT1 gene with subgroups of BD. BD patients from a Swedish cohort (N = 831) were phenotyped in regards to their psychotic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
